Insider filing · DXCM
Jon Coleman
EVP, Chief Commercial Officer
profile →
DexCom, Inc.
DXCM · Healthcare · 49 filings in 24 months
ticker →
Jon Coleman sold $723K of DexCom (DXCM)
Executed Jun 3, disclosed Jun 5, 2 days later.
Value, as filed
$723K
9,823 sh across 2 lots
Executed
Jun 3
the trade date, as filed
Disclosed
Jun 5
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JCJon Coleman (EVP, Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in DexCom, Inc. (DXCM). The largest single filing was $723K of DXCM (9,823 sh across 2 lots, as filed), executed Jun 3.
The name
DXCMHealthcare · DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) sy…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→